Your browser doesn't support javascript.
loading
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
Araujo, Angela M; Abaurrea, Andrea; Azcoaga, Peio; López-Velazco, Joanna I; Manzano, Sara; Rodriguez, Javier; Rezola, Ricardo; Egia-Mendikute, Leire; Valdés-Mora, Fátima; Flores, Juana M; Jenkins, Liam; Pulido, Laura; Osorio-Querejeta, Iñaki; Fernández-Nogueira, Patricia; Ferrari, Nicola; Viera, Cristina; Martín-Martín, Natalia; Tzankov, Alexandar; Eppenberger-Castori, Serenella; Alvarez-Lopez, Isabel; Urruticoechea, Ander; Bragado, Paloma; Coleman, Nicholas; Palazón, Asís; Carracedo, Arkaitz; Gallego-Ortega, David; Calvo, Fernando; Isacke, Clare M; Caffarel, María M; Lawrie, Charles H.
Afiliación
  • Araujo AM; Biodonostia Health Research Institute, San Sebastian, Spain.
  • Abaurrea A; Biodonostia Health Research Institute, San Sebastian, Spain.
  • Azcoaga P; Biodonostia Health Research Institute, San Sebastian, Spain.
  • López-Velazco JI; Biodonostia Health Research Institute, San Sebastian, Spain.
  • Manzano S; Biodonostia Health Research Institute, San Sebastian, Spain.
  • Rodriguez J; Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain.
  • Rezola R; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain.
  • Egia-Mendikute L; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
  • Valdés-Mora F; Cancer Epigenetic Biology and Therapeutics Laboratory, Children's Cancer Institute, Sydney, New South Wales, Australia.
  • Flores JM; School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Jenkins L; Department of Animal Medicine and Surgery, Complutense University of Madrid, Madrid, Spain.
  • Pulido L; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Osorio-Querejeta I; Biodonostia Health Research Institute, San Sebastian, Spain.
  • Fernández-Nogueira P; Biodonostia Health Research Institute, San Sebastian, Spain.
  • Ferrari N; Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine and.
  • Viera C; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Martín-Martín N; Tumour Microenvironment Lab, The Institute of Cancer Research, London, United Kingdom.
  • Tzankov A; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
  • Eppenberger-Castori S; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Alvarez-Lopez I; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
  • Urruticoechea A; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
  • Bragado P; Traslational Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Bizkaia, Spain.
  • Coleman N; Institute of Medical Genetics and Pathology, University Hospital, Basel, Switzerland.
  • Palazón A; Institute of Medical Genetics and Pathology, University Hospital, Basel, Switzerland.
  • Carracedo A; Biodonostia Health Research Institute, San Sebastian, Spain.
  • Gallego-Ortega D; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain.
  • Calvo F; Biodonostia Health Research Institute, San Sebastian, Spain.
  • Isacke CM; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain.
  • Caffarel MM; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.
  • Lawrie CH; Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain.
J Clin Invest ; 132(7)2022 04 01.
Article en En | MEDLINE | ID: mdl-35192545

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Microambiente Tumoral Límite: Animals / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Microambiente Tumoral Límite: Animals / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article